
1. zhongguo zhong yao za zhi. 2018 oct;43(20):4019-4026. doi:
10.19540/j.cnki.cjcmm.20180517.001.

[ferroptosis pathway intervention regulated chinese materia medica].

[article chinese]

xu wh(1)(2), li ch(2), jiang tl(2).

author information: 
(1)research center artemisinin, china academy chinese medical sciences,
beijing 100700, china.
(2)tang center herbal medicine research, institute chinese materia medica,
china academy chinese medical sciences, beijing 100700, china.

ferroptosis new form regulated cell death different from
apoptosis, necrosis autophagy, results iron-dependent lipidperoxide 
accumulation. now, found ferroptosis involved multiple
physiological pathological processes, cancer, arteriosclerosis,
neurodegenerative diseases, diabetes, antiviral immune response, acute renal
failure, hepatic heart ischemia/reperfusion injury. one hand, could
be found appropriate drugs promote ferroptosis clear cancer cells and
virus infected cells, etc. hand, could inhibit ferroptosis to
protect healthy cells. china wealth traditional chinese medicine
resources. chinese medicine contains variety active ingredients that
regulate ferroptosis. here, paper reported research ferroptosis
pathway, targets inducers inhibitors discovered, and
the regulatory effects discovered chinese herbs active ingredients
on ferroptosis help clinical scientific research.

copyrightÂ© chinese pharmaceutical association.

doi: 10.19540/j.cnki.cjcmm.20180517.001 
pmid: 30486525  [indexed medline]

conflict interest statement: authors article planning
committee members staff relevant financial relationships with
commercial interests disclose.

